TMO
NYSE
$526.23
Thermo Fisher Scientific Inc (TMO)
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $591.27 (+12.36%)
Market Cap
$199B
Forward P/E
21.41
P/E Ratio
31.53
Free Cash Flow Yield
3.39%
Price Chart
Valuation
Market Cap$199B
P/E31.53
Forward P/E21.41
PEG6.52
P/S4.39
P/B3.78
Profitability
Total Revenue (TTM)$45B
Gross Profit (TTM)$19B
EBITDA$8.97B
Profit Margin15%
Operating Margin16.9%
EPS$16.98
Financial Health
Debt-to-Equity88.6%
Free Cash Flow Yield3.39%
Dividend Yield0.32%
Growth & Risk
EPS 5Y CAGR+14.94%
Revenue 5Y CAGR+4.72%
FCF 5Y CAGR-3.50%
Dividends 5Y CAGR+13.40%
Beta (5Y)0.77
Sharpe Ratio0.73